Dexrazoxane for cardiac protection against doxorubicin.
D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control*; D004317:Doxorubicin / Q000633:toxicity*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011929:Razoxane / Q000009:adverse effects / Q000627:therapeutic use*
D011929:Razoxane; D004317:Doxorubicin